# Parotid-sparing IMRT for Nasopharyngeal Cancer

> **NCT02149641** · — · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 42 (actual)

## Conditions studied

- Nasopharyngeal Cancers
- Intensity Modulated Radiotherapy With Chemotherapy

## Interventions

- **RADIATION:** Intensity modulated radiotherapy with chemotherapy

## Key facts

- **NCT ID:** NCT02149641
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2011-04
- **Final completion:** 2012-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149641, "Parotid-sparing IMRT for Nasopharyngeal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02149641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*